Deerfield Partners, L.p. - Net Worth and Insider Trading

Deerfield Partners, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deerfield Partners, L.p. owns 51 companies in total, including Oncorus Inc (ONCR) , CalciMedica Inc (CALC) , and Acutus Medical Inc (AFIB) among others .

Click here to see the complete history of Deerfield Partners, L.p.’s form 4 insider trades.

Insider Ownership Summary of Deerfield Partners, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
ONCR	Oncorus Inc	2020-10-01	director & 10 percent owner & other: *Possible Member of 10% Group
CALC	CalciMedica Inc	2020-09-24	10 percent owner & other: Possible Member of 10% Group
AFIB	Acutus Medical Inc	2020-08-05	director & 10 percent owner & other: Director by Deputization
		2020-07-23	10 percent owner & other: Possible Member of 10% Group
		2020-07-21	director & 10 percent owner & other: Director by Deputization
		2020-07-09	10 percent owner & other: Possible Member of 10% Group
		2020-06-11	10 percent owner & other: Possible Member of 10% Group
		2020-03-13	director & 10 percent owner & other: Director by Deputization
		2020-02-12	10 percent owner & other: Possible Member of 10% Group
		2020-02-10	10 percent owner & other: Possible Member of 10% Group
		2020-01-29	10 percent owner & other: Possible Member of 10% Group
		2018-04-02	director & 10 percent owner & other: *Director by Deputization
		2019-10-24	10 percent owner & other: Possible Member of 10% Group
		2019-10-07	10 percent owner & other: Possible Member of 10% Group
		2018-10-22	10 percent owner & other: Possible Member of 10% Group
		2018-07-23	10 percent owner & other: Possible Member of 10% Group
		2018-05-29	10 percent owner & other: *Possible member of 10% group
		2018-05-08	10 percent owner & other: *Possible member of 10% group
		2018-02-15	10 percent owner & other: Possible Member of 10% Group
		2017-08-02	director & other: *Director by Deputization
		2016-12-16	10 percent owner & other: Possible Member of 10% Group
		2014-08-01	10 percent owner & other: Possible Member of 10% Group
		2014-12-23	10 percent owner & other: Possible Member of 10% Group
		2016-02-09	10 percent owner & other: Possible Member of 10% Group
		2016-02-19	10 percent owner & other: Possible Member of 10% Group
		2016-02-17	10 percent owner & other: Possible Member of 10% Group
		2015-05-11	10 percent owner & other: Possible Member of 10% Group
		2015-09-22	10 percent owner & other: Possible Member of 10% Group
		2014-08-06	10 percent owner & other: Possible Members of 10% Group
		2014-08-05	10 percent owner & other: Possible Members of 10% Group
		2012-12-04	10 percent owner & other: Possible Member of 10% Group
		2010-11-03	10 percent owner & other: Possible Members of 10% Group
		2011-04-04	10 percent owner & other: Possible Members of 10% Group
		2007-10-19	10 percent owner
		2006-01-31	10 percent owner & other: Possible Members of 10% Group
		2021-04-29	10 percent owner & other: Possible Member of 10% Group
		2020-03-10	director & 10 percent owner & other: *Director by Deputization
		2020-07-16	director & 10 percent owner & other: *Director by Deputization
		2020-02-04	10 percent owner & other: Possible Member of 10% Group
		2020-02-01	10 percent owner & other: Possible Member of 10% Group
		2022-05-05	10 percent owner & other: *Possible Member of 10% Group
		2021-10-21	10 percent owner & other: *Possible Member of 10% Group
		2021-05-26	10 percent owner & other: *Possible Member of 10% Group
		2021-07-27	director & 10 percent owner & other: Director by deputization
		2020-02-01	10 percent owner & other: Possible Member of 10% Group
		2018-05-08	10 percent owner & other: *Possible member of 10% group
		2020-02-01	10 percent owner & other: Possible Member of 10% Group
		2022-11-03	director & 10 percent owner & other: Director by Deputization
		2022-11-08	10 percent owner & other: Possible Member of 10% Group
		2022-11-08	10 percent owner & other: Possible Member of 10% Group
		2019-10-07	10 percent owner & other: Possible Member of 10% Group

Deerfield Partners, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deerfield Partners, L.p. Ownership Network

Ownership Network List of Deerfield Partners, L.p.

No Data

Ownership Network Relation of Deerfield Partners, L.p.

Deerfield Partners, L.p. Owned Company Details

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: *Possible Member of 10% Group of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncorus Inc Insider Transactions

No Available Data

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 20,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CalciMedica Inc Insider Transactions

No Available Data

What does Acutus Medical Inc do?

Who are the key executives at Acutus Medical Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: Director by Deputization of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .

Acutus Medical Inc (AFIB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acutus Medical Inc Insider Transactions

No Available Data

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Financial Officer Jennifer Lew , EVP & Chief Innovation Officer Ted Yednock , and EVP & Chief Business Officer Michael Overdorf .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .

In summary, during the past 3 months, insiders sold 7,148 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 748 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,303,458 shares were bought by its insiders, resulting in a net purchase of 3,230,344 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Deerfield Healthcare Technology Acquisitions Corp do?

Who are the key executives at Deerfield Healthcare Technology Acquisitions Corp?

Deerfield Partners, L.p. is the director & 10 percent owner & other: Director by Deputization of Deerfield Healthcare Technology Acquisitions Corp. Other key executives at Deerfield Healthcare Technology Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .

Deerfield Healthcare Technology Acquisitions Corp (DFHTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Deerfield Healthcare Technology Acquisitions Corp Insider Transactions

No Available Data

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Nkarta Inc. Other key executives at Nkarta Inc include 10 percent owner Ra Capital Healthcare Fund Lp , Chief Scientific Officer James Trager , and Chief Medical Officer David Shook .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 5,000,000 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nkarta Inc Insider Transactions

No Available Data

What does Generation Bio Co do?

Who are the key executives at Generation Bio Co?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .

Generation Bio Co (GBIO) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Generation Bio Co Insider Transactions

No Available Data

What does DFP Healthcare Acquisitions Corp do?

Who are the key executives at DFP Healthcare Acquisitions Corp?

Deerfield Partners, L.p. is the director & 10 percent owner & other: Director by Deputization of DFP Healthcare Acquisitions Corp. Other key executives at DFP Healthcare Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization James E Flynn .

DFP Healthcare Acquisitions Corp (DFPHU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

DFP Healthcare Acquisitions Corp Insider Transactions

No Available Data

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include Chief Financial Officer Jack Anders , director & See Remarks Mark A Goldsmith , and General Counsel Jeff Cislini .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 91,644 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 68,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 68,164 shares. During the past 18 months, 337,190 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 312,810 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does Schrodinger Inc do?

Who are the key executives at Schrodinger Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Schrodinger Inc. Other key executives at Schrodinger Inc include EVP & CFO Geoffrey Craig Porges , See Remarks Robert Lorne Abel , and See Remarks Yvonne Tran .

Schrodinger Inc (SDGR) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 60,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 66,886 shares made by Ramy Farid .

In summary, during the past 3 months, insiders sold 3,315 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 3,315 shares. During the past 18 months, 168,702 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,702 shares.

Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Schrodinger Inc Insider Transactions

No Available Data

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

What does Homology Medicines Inc do?

Who are the key executives at Homology Medicines Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: *Director by Deputization of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .

Homology Medicines Inc (FIXX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Homology Medicines Inc Insider Transactions

No Available Data

What does Cabaletta Bio Inc do?

Who are the key executives at Cabaletta Bio Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .

Cabaletta Bio Inc (CABA) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cabaletta Bio Inc Insider Transactions

No Available Data

What does Frequency Therapeutics Inc do?

Who are the key executives at Frequency Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .

Frequency Therapeutics Inc (FREQ) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.

Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Frequency Therapeutics Inc Insider Transactions

No Available Data

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aclaris Therapeutics Inc Insider Transactions

No Available Data

What does Aerie Pharmaceuticals Inc do?

Who are the key executives at Aerie Pharmaceuticals Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .

Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerie Pharmaceuticals Inc Insider Transactions

No Available Data

What does Kiniksa Pharmaceuticals Ltd do?

Who are the key executives at Kiniksa Pharmaceuticals Ltd?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible member of 10% group of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .

Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 68,156 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 197,552 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 197,552 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiniksa Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , EVP & Chief Sci. Ofcr Steven J. Romano , and 10 percent owner Fyi S.a R.l. .

Mallinckrodt PLC (MNKKQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Deerfield Partners, L.p. is the director & other: *Director by Deputization of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 197,773 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 182,300 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 182,300 shares. During the past 18 months, 197,773 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 197,773 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protara Therapeutics Inc Insider Transactions

No Available Data

What does Societal CDMO Inc do?

Who are the key executives at Societal CDMO Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Societal CDMO Inc. Other key executives at Societal CDMO Inc include director & Chief Executive Officer Enloe J David Jr , director & 10 percent owner Mathew Paul Arens , and 10 percent owner Awm Investment Company, Inc. .

Societal CDMO Inc (SCTL) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net sale of 230,000 shares made by Awm Investment Company, Inc. , a net purchase of 125,660 shares made by Enloe J David Jr , and a net purchase of 6,250,000 shares made by Mathew Paul Arens .

In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 370,000 shares of Societal CDMO Inc (SCTL) were sold and 6,792,882 shares were bought by its insiders, resulting in a net purchase of 6,422,882 shares.

Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Societal CDMO Inc Insider Transactions

No Available Data

What does eHealth Inc do?

Who are the key executives at eHealth Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of eHealth Inc. Other key executives at eHealth Inc include SVP & General Counsel & Secr. Gavin G. Galimi , director & Chief Executive Officer Soistman Francis S Jr , and SVP & Chief Financial Officer John J Stelben .

eHealth Inc (EHTH) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 22,932 shares made by Dale B Wolf , a net purchase of 7,500 shares made by Gavin G. Galimi , and a net purchase of 80,000 shares made by Soistman Francis S Jr .

In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000 shares of eHealth Inc (EHTH) were sold and 115,432 shares were bought by its insiders, resulting in a net purchase of 110,432 shares.

eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

eHealth Inc Insider Transactions

No Available Data

What does Vanda Pharmaceuticals Inc do?

Who are the key executives at Vanda Pharmaceuticals Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include director & Chief Executive Officer Mihael Hristos Polymeropoulos , SVP & General Counsel Timothy Williams , and SVP & Business Development Gunther Birznieks .

Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vanda Pharmaceuticals Inc Insider Transactions

No Available Data

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc (LRMR) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Michael Celano , and a net purchase of 5,000 shares made by Carole Ben-maimon .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Larimar Therapeutics Inc Insider Transactions

No Available Data

What does XenoPort Inc do?

Who are the key executives at XenoPort Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of XenoPort Inc. Other key executives at XenoPort Inc include See Remarks William G Harris , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

XenoPort Inc (XNPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

XenoPort Inc Insider Transactions

No Available Data

What does AveXis Inc do?

Who are the key executives at AveXis Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .

AveXis Inc (AVXS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

AveXis Inc Insider Transactions

No Available Data

What does Antares Pharma Inc do?

Who are the key executives at Antares Pharma Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .

Antares Pharma Inc (ATRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Antares Pharma Inc Insider Transactions

No Available Data

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regenxbio Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by James Paul Scopa , and a net purchase of 100,000 shares made by Linda M Rubinstein .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adverum Biotechnologies Inc Insider Transactions

No Available Data

What does NxStage Medical Inc do?

Who are the key executives at NxStage Medical Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of NxStage Medical Inc. Other key executives at NxStage Medical Inc include director & Chief Executive Officer Jeffrey H Burbank , Chief Accounting Officer Kevin Hershberger , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .

NxStage Medical Inc (NXTM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

NxStage Medical Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does The Medicines Co do?

Who are the key executives at The Medicines Co?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Members of 10% Group of The Medicines Co. Other key executives at The Medicines Co include Chief Development Officer Peter Wijngaard , EVP & Chief Corp. Dev. Officer Christopher T Cox , and director & Executive Chairman Fredric N Eshelman .

The Medicines Co (MDCO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co (MDCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co (MDCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

The Medicines Co (MDCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

The Medicines Co Insider Transactions

No Available Data

What does Arena Pharmaceuticals Inc do?

Who are the key executives at Arena Pharmaceuticals Inc?

Deerfield Partners, L.p. is the 10 percent owner of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .

Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arena Pharmaceuticals Inc Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Members of 10% Group of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 186,515 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,783,800 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,783,800 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 1,853,000 shares made by Ra Capital Healthcare Fund Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 1,853,000 shares were bought by its insiders, resulting in a net purchase of 1,853,000 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Werewolf Therapeutics Inc Insider Transactions

No Available Data

What does The Oncology Institute Inc do?

Who are the key executives at The Oncology Institute Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: *Director by Deputization of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include 10 percent owner Havencrest Healthcare Partners, L.p. , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and director & Chief Executive Officer Brad Hively .

The Oncology Institute Inc (TOI) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 81,718 shares made by Brad Hively , a net sale of 80,000 shares made by Havencrest Healthcare Partners, L.p. , and a net purchase of 73,107 shares made by Matthew P Miller .

In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 182,445 shares of The Oncology Institute Inc (TOI) were sold and 223,684 shares were bought by its insiders, resulting in a net purchase of 41,239 shares.

The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.

The Oncology Institute Inc Insider Transactions

No Available Data

What does CareMax Inc do?

Who are the key executives at CareMax Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: *Director by Deputization of CareMax Inc. Other key executives at CareMax Inc include director & 10 percent owner De La Torre Ralph , EVP and COO Solo Alberto De , and director & President and CEO De Solo Carlos A. .

CareMax Inc (CMAX) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in CareMax Inc (CMAX). Other recent insider transactions involving CareMax Inc (CMAX) include a net purchase of 10,000 shares made by Bryan Cho ,

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAX) were sold and 333 shares were bought by its insiders, resulting in a net purchase of 333 shares.

CareMax Inc (CMAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CareMax Inc Insider Transactions

No Available Data

What does Terns Pharmaceuticals Inc do?

Who are the key executives at Terns Pharmaceuticals Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Financial Officer Mark J. Vignola , and COO and General Counsel Seokho Bryan Yoon .

Terns Pharmaceuticals Inc (TERN) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 10,743 shares made by Seokho Bryan Yoon , a net purchase of 10,743 shares made by Mark J. Vignola , and a net purchase of 337,957 shares made by Vivo Opportunity Fund Holdings, L.p. .

In summary, during the past 3 months, insiders sold 420,663 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 0 shares, with a net sale of 420,663 shares. During the past 18 months, 1,920,663 shares of Terns Pharmaceuticals Inc (TERN) were sold and 1,816,702 shares were bought by its insiders, resulting in a net sale of 103,961 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Terns Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Ignyte Acquisition Corp (IGNYU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does PepGen Inc do?

Who are the key executives at PepGen Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible Member of 10% Group of PepGen Inc. Other key executives at PepGen Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , director & President and CEO James G Mcarthur , and See Remarks Jaya Goyal .

PepGen Inc (PEPG) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 29,556 shares made by James G Mcarthur , a net sale of 6,392 shares made by Jaya Goyal , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,642 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,521,645 shares.

PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.

PepGen Inc Insider Transactions

No Available Data

What does Xilio Therapeutics Inc do?

Who are the key executives at Xilio Therapeutics Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible Member of 10% Group of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and Chief Operating Officer Christopher James Frankenfield .

Xilio Therapeutics Inc (XLO) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xilio Therapeutics Inc Insider Transactions

No Available Data

What does Singular Genomics Systems Inc do?

Who are the key executives at Singular Genomics Systems Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible Member of 10% Group of Singular Genomics Systems Inc. Other key executives at Singular Genomics Systems Inc include director & 10 percent owner & Chief Executive Officer Andrew Spaventa , Chief Scientific Officer Eli N. Glezer , and Chief Operating Officer Jyotsna Ghai .

Singular Genomics Systems Inc (OMIC) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 420,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar , and a net purchase of 118,468 shares made by Andrew Spaventa .

In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 631,648 shares of Singular Genomics Systems Inc (OMIC) were sold and 538,468 shares were bought by its insiders, resulting in a net sale of 93,180 shares.

Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Singular Genomics Systems Inc Insider Transactions

No Available Data

What does DA32 Life Science Tech Acquisition Corp do?

Who are the key executives at DA32 Life Science Tech Acquisition Corp?

Deerfield Partners, L.p. is the director & 10 percent owner & other: Director by deputization of DA32 Life Science Tech Acquisition Corp. Other key executives at DA32 Life Science Tech Acquisition Corp include director & 10 percent owner Keith Crandell , director & 10 percent owner & other: Director by deputization Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Director by Deputization Section 32 Fund 3, Lp .

DA32 Life Science Tech Acquisition Corp (DALS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

DA32 Life Science Tech Acquisition Corp Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include 10 percent owner Ignyte Sponsor Llc , director & 10 percent owner & Co-Chief Executive Officer David I. Rosenberg , and director & 10 percent owner & Co-Chief Executive Officer David J. Strupp .

Ignyte Acquisition Corp (IGNY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Deerfield Partners, L.p. is the 10 percent owner & other: *Possible member of 10% group of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include 10 percent owner Alta Fundamental Advisers Llc , EVP & Head of Corp Development Jason Daniel Goodson , and director & President and CEO Sigurdur O Olafsson .

Mallinckrodt PLC (MCKPF) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Mallinckrodt PLC (MCKPF). Other recent insider transactions involving Mallinckrodt PLC (MCKPF) include a net purchase of 30,000 shares made by James R Sulat , a net purchase of 5,000 shares made by Paul Bisaro , and a net purchase of 3,000 shares made by Sigurdur O Olafsson .

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 40,133 shares were bought by its insiders, resulting in a net purchase of 40,133 shares.

Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

What does Peak Bio Inc do?

Who are the key executives at Peak Bio Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Peak Bio Inc (PKBO) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,

In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.

Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Peak Bio Inc Insider Transactions

No Available Data

What does Nuvalent Inc do?

Who are the key executives at Nuvalent Inc?

Deerfield Partners, L.p. is the director & 10 percent owner & other: Director by Deputization of Nuvalent Inc. Other key executives at Nuvalent Inc include Chief Legal Officer Deborah Ann Miller , See Remarks Darlene Noci , and Chief Financial Officer Alexandra Balcom .

Nuvalent Inc (NUVL) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 135,400 shares made by Darlene Noci , a net sale of 97,578 shares made by Deborah Ann Miller , and a net sale of 523,100 shares made by Matthew Shair .

In summary, during the past 3 months, insiders sold 1,212,833 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 1,212,833 shares. During the past 18 months, 1,737,971 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,737,971 shares.

Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nuvalent Inc Insider Transactions

No Available Data

What does Frazier Lifesciences Acquisition Corp do?

Who are the key executives at Frazier Lifesciences Acquisition Corp?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .

Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Frazier Lifesciences Acquisition Corp Insider Transactions

No Available Data

What does Frazier Lifesciences Acquisition Corp do?

Who are the key executives at Frazier Lifesciences Acquisition Corp?

Frazier Lifesciences Acquisition Corp (FLACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Frazier Lifesciences Acquisition Corp (FLACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Frazier Lifesciences Acquisition Corp Insider Transactions

No Available Data

What does Korro Bio Inc do?

Who are the key executives at Korro Bio Inc?

Deerfield Partners, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Korro Bio Inc. Other key executives at Korro Bio Inc include 10 percent owner Scott D Sandell , 10 percent owner New Enterprise Associates 17, L.p. , and 10 percent owner Rick Yang .

Korro Bio Inc (KRRO) Insider Trades Summary

Over the past 18 months, Deerfield Partners, L.p. made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by Paul Edward Walker , and a net purchase of 17,857 shares made by Rick Yang .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 178,570 shares, with a net purchase of 178,570 shares. During the past 18 months, 2,124 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 176,446 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Korro Bio Inc Insider Transactions

No Available Data

Deerfield Partners, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Deerfield Partners, L.p.. You might contact Deerfield Partners, L.p. via mailing address: 345 Park Avenue South, 12th Floor, New York Ny 10010.

Discussions on Deerfield Partners, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.